Funded Tech Companies
Amber Bio
Amber Bio is a biopharmaceutical company, based in San Francisco. Investment was provided by Eli Lilly and Company, Pillar VC and Playground Global.
Company Overview
Company Name
Amber Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
953 Indiana St
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/3/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Borrajo
Chief Technical Officer
Basem Al-Shayeb
Company Investors
- Eli Lilly and Company
- Pillar VC
- Playground Global
- Hummingbird Ventures
- Andreessen Horowitz
- Retinal Degeneration
Browse more funded tech companies:
Amber Agriculture | Amber Group
Share this article
About Our Venture Capital Transactions Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs